Gabrielle Sulzberger - 17 Jun 2021 Form 4 Insider Report for Cerevel Therapeutics Holdings, Inc.

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
+$275,357
Form type
4
Filing time
22 Jun 2021, 18:31:45 UTC
Previous filing
14 Jun 2021
Next filing
24 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Purchase $275,357 +21,084 +148% $13.06 35,354 17 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.